GlassScriptPhysician profile
Maria Felipe
NPI 1134484538
$788.83
in general payments reported to CMS, 2019-2025
14 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $80.27 · 2022: $285 · 2023: $196 · 2024: $95.41 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $424.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $424.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $400.52 | 2022-2025 | Nucala, Trelegy Ellipta |
| Lilly USA, LLC | $75.84 | 2022-2023 | Mounjaro |
| Sunovion Pharmaceuticals INC. | $42.02 | 2021 | |
| Dexcom, INC. | $40.94 | 2023 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $36.47 | 2022 | |
| Inspire Medical Systems, INC. | $34.04 | 2025 | Inspire |
| Merck Sharp & Dohme LLC | $29.10 | 2022 | |
| Nabriva Therapeutics, Plc | $28.80 | 2021-2022 | |
| Edwards Lifesciences Corporation | $27.30 | 2022 | |
| Exact Sciences Corporation | $19.39 | 2023 | Cologuard Collection Kit |
| Mannkind Corporation | $16.99 | 2023 | Afrezza |
| Abbott Laboratories | $13.33 | 2021 | |
| Abbvie INC. | $12.97 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Felipe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.